Cozaar News
Teva's horizon - Globes
... with generic launches of drugs such as the anti depressant Effexor (estimated sales of $445 million), the hypertension drug Hyzaar/Cozaar (estimated ...
Nutrition counseling available - Belleville News Democrat
The drug, losartan (band name Cozaar), lowers the activity of the protein-transforming growth factor beta, which researchers have found to be the likely ...
Merck Says Growth Is on Target; Drug Development Is Progressing - Wall Street Journal
By 2012, Merck will face generic competition to its three top-selling drugs: Fosamax, Singulair and the blood-pressure drug Cozaar. ...
dupont's Holliday Says US Recession Is Unlikely (Update2) - Bloomberg
Hypertension treatments Cozaar and Hyzaar, marketed through Merck & Co., lose US patent protection in 2010. They added $819 million to dupont's profit last ...
DuPont's Holliday Says US Recession Is Unlikely (Update1) - Bloomberg
Hypertension treatments Cozaar and Hyzaar, marketed through Merck & Co., lose US patent protection in 2010. They added $819 million to DuPont's profit last ...
Nutrition counseling available - Belleville News Democrat
The drug, losartan (band name Cozaar), lowers the activity of the protein-transforming growth factor beta, which researchers have found to be the likely ...
dupont's Holliday Says US Recession Is Unlikely (Update2) - Bloomberg
Hypertension treatments Cozaar and Hyzaar, marketed through Merck & Co., lose US patent protection in 2010. They added $819 million to dupont's profit last ...
Big Pharma Faces Grim Prognosis - Wall Street Journal
... face generic competition to its three top-selling drugs: the osteoporosis treatment Fosamax, Singulair for asthma and the blood-pressure drug Cozaar. ...
3rd UPDATE: Merck Sees 2008 Earnings Below Analysts' View - CNNMoney.com
Combined sales of anti-hypertension drugs Cozaar and Hyzaar, however, are expected to be flat at $3.2 billion to $3.4 billion . Merck also may introduce ...
Tough Roads Loom Ahead for US Pharmaceutical Giants - DailyTech
Three high profile medications from Merck & Co have patents expiring in 2012 including Fosamax, Singulair and Cozaar. Those three drugs combine to provide ...
Cozaar RSS Feed